Featured News
AIM Blog
Recognizing AIM’s January Advocate of the Month: Ben Woodworth
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Joanne Pike, DrPH, Alzheimer’s Association President and CEO, Testifies Before Congress on Key Alzheimer’s Priorities
Passionate Advocates Paint Hearing Purple WASHINGTON, D.C., Feb. 14, 2024 — Joanne Pike, DrPH, Alzheimer’s Association president and CEO and...
Press Release
Senate Takes BOLD Step to Strengthen the Nation’s Dementia Public Health Infrastructure
Washington, D.C., Feb. 8, 2024 — The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support today’s...
Press Release
House Introduces Bipartisan Legislation to Renew BOLD Commitment to Dementia Public Health Infrastructure
Washington, D.C., February 5, 2024 — Today, the House began renewing our nation’s commitment to strengthening the dementia public health...
AIM Blog
Recognizing AIM’s February Advocate of the Month: Pamela Talley
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Biogen’s Decision to Discontinue Alzheimer’s Drug
CHICAGO, Jan. 31, 2024 — Despite today’s announcement from Biogen, the Alzheimer’s Association is extremely optimistic about the future of...
AIM Blog
To Improve the Early Detection and Diagnosis of Alzheimer’s, States Need to Ensure Access to Biomarker Testing
With the historic Food and Drug Administration (FDA) approval of treatments that slow the progression of Alzheimer’s in the early...